PMC:7696151 / 76643-76784 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2242","span":{"begin":13,"end":30},"obj":"Gene"},{"id":"2250","span":{"begin":94,"end":103},"obj":"Chemical"},{"id":"2270","span":{"begin":40,"end":54},"obj":"Disease"}],"attributes":[{"id":"A2242","pred":"tao:has_database_id","subj":"2242","obj":"Gene:2099"},{"id":"A2250","pred":"tao:has_database_id","subj":"2250","obj":"MESH:D013629"},{"id":"A2270","pred":"tao:has_database_id","subj":"2270","obj":"MESH:D001943"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In addition, estrogen receptor-positive breast cancers developed resistance to treatment with tamoxifen, due to the enhancement of autophagy."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T157","span":{"begin":40,"end":54},"obj":"Phenotype"}],"attributes":[{"id":"A157","pred":"hp_id","subj":"T157","obj":"http://purl.obolibrary.org/obo/HP_0003002"}],"text":"In addition, estrogen receptor-positive breast cancers developed resistance to treatment with tamoxifen, due to the enhancement of autophagy."}

{"project":"LitCovid-sentences","denotations":[{"id":"T492","span":{"begin":0,"end":141},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition, estrogen receptor-positive breast cancers developed resistance to treatment with tamoxifen, due to the enhancement of autophagy."}